Short News

Anthropic IPO: Research Firm Values AI Company At $150 Billion, Calls Offering ‘Most Ridiculous Of 2026’

Published by
Anjali Belgaumkar

As Anthropic heads toward a possible $2 trillion Nasdaq valuation, independent research firm New Constructs says the company is worth about $150 billion and calls the planned listing the “most ridiculous IPO of 2026.” It estimates Anthropic would need to earn roughly double Nvidia’s trailing-year net income, which topped $190 billion, to justify that price. Reuters, citing a leaked prospectus, reported 2025 revenue of $4.6 billion and a net loss of $42 billion. Founder David Trainer, a known IPO bear, said open-source models make it hard for closed models to turn a profit and concluded, “We don’t think Anthropic has a viable business.” His record is mixed. He correctly flagged WeWork in 2019, but his 2020 pick, DoorDash, has since grown to an $83 billion market cap.

Anjali Belgaumkar

Writer by choice, CryptoCurrency Writer, and Researcher by chance. Currently, focusing on financial news and analysis, as well as cryptocurrency news and data. One may not call me a crypto “Enthusiast” but trust me I'm getting there.

Recent Posts

Ethereum Price Analysis: Are Whales Preparing for a Rebound as Retail Traders Exit

The Ethereum price has been facing tremendous selling pressure ever since it broke the crucial…

November 17, 2026

XRP News Today: Whales Pull $127 Million From Binance as Price Holds Below $1

XRP whales have taken more than $127 million out of Binance since November 10, based…

November 17, 2026

Disney (DIS) Stock Rally After Earnings Beat as Investors Weigh 2027 Outlook

Disney (DIS) stock is back in focus after the company delivered a quarterly earnings beat…

November 17, 2026

Hut 8 Corp (HUT) Stock Price Prediction 2026, 2027, 2030 – 2040: Is HUT the Best AI Crypto Stock to Buy?

As artificial intelligence reshapes digital infrastructure, Hut 8 Corp. (NASDAQ: HUT) is positioning itself beyond…

November 17, 2026

SLS Stock Soars More Than 200% After Phase 3 Cancer Vaccine Success: What’s Next for SELLAS Life Sciences?

SLS stock has skyrocketed more than 200%, putting SELLAS Life Sciences among the market's biggest…

November 17, 2026

Magnificent 7 US Stocks : Meta, Amazon and Nvidia Lead the Buy List

The Magnificent 7 US stocks are facing renewed selling pressure as investors reassess technology valuations…

November 17, 2026